Materiale fra DBCG Seminar 2023
Præsentationer fra Dag 1 – Mandag d. 13. November
- Velkomst
- Hvordan virker behandlingen – baseret på relevant opsamling af data?
- Hvordan Kan Vi Hjælpe Patienter Med At Få Fri Fra Riget I Deres Opfølgningsforløb?
- Hvad forventer en brystkræftpatient sig af sin opfølgning?
- Hvem er den sårbare patient med brystkræft – og hvordan sikrer vi det bedst mulige forløb for disse patienter?
- Hvad kan afhjælpe biopsykosociale konsekvenser af kræft og kræftbehandling?
- Kræftrehabilitering I Kommunerne
- Opfølgning af patienter der er opereret for brystkræft – Jobcenter
- Opfølgning – Genetik
- Opfølgning i det nære sundhedsvæsen – almen praksis
- Sekundære sygdomme til behandling for brystkræft
- Opfølgning systemetisk behandling
- Opfølgning – Lokoregionalt recidiv og andre problemstillinger
Gruppe præsentationer fra Dag 2 – Tirsdag d. 13. November
- Gr. 1 Datafangst
- Gr. 2 Lokoregional Opfølgning
- Gr. 3 Opfølgning I Kommunen
- Gr. 4 Opfølgning Hos Egen Læge
- Gr. 5 Identifcering Og Opføgning Af Sekundære Sygdomme
- Gr. 6 Identificering Og Opfølgning Af Gener Efter Endokrin Behandling
- Gr. 7 Identificering Og Opfølgning Af Gener Efter Kemoterapi
- Gr. 8 Opfølgningskadence: / Compliance (Sårbare Grupper
Planlæg 2024 sammen med os – book et møde
Gruppe 1: Datafangst
- Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V
- Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study
- Patterns in detection of recurrence among patients treated for breast cancer
- DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer
- The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis
- Identifying Recurrent Breast Cancer Patients In National Health Registries Using Machine Learning
- Artzi Et Al. 2023 Real World Survival Of Danish Patients With HER2 P
Gruppe 2: Lokoregional opfølgning
- Breast cancer survivors’ risk of interval cancers and false positive results in organized mammography screening
- Development in self-reported arm-lymphedema in Danish women treated for early-stage breast cancer in 2005 and 2006 e A nationwide follow-up study
- Imaging Surveillance After Primary Breast Cancer Treatment
- Persistent pain, sensory disturbances and functional impairment after immediate or delayed axillary lymph node dissection
- Prevalence of and Factors Associated With Persistent Pain Following Breast Cancer Surgery
- Self Reported Arm Lymphedema And Functional Impairment After Breast Cancer
- Surgical Treatment Of Lymphedema A Systematic Review And Meta Analysis Of Controlled Trials. Results Of A Consensus Conference
- Assessing Mode Of Recurrence In Breast Cancer To Identify
Gruppe 3: Opfølgning i kommunen
- Sundhedsloven §140
- Sundhedsloven §119
- Lov Om Sygedagpenge §27
- Lov Om Sygedagpenge §13B
- Postoperativ genoptræning og forebyggelse af senfølger i overkroppen
- Brystkræft – fysisk træning under kemoterapi for brystkræft
- Brystkræft – Opfølgning og kontrol
- Jobcentret er der for alle – også ved alvorlig sygdom
- Forløbsprogram For Rehabilitering Og Palliation I Forbindelse Med Kræft
Gruppe 4: Opfølgning hos egen læge
- Health Care Use And Remaining Needs For Support Among Women With Breast Cancer The Role Of The GP
- The Role Of General Practice In Cancer Care
- Risk Factors Of Unmet Needs Among Women With Breast Cancer In The Post Treatment Phase
- Improving Communication Between The General Practitioner And The Oncologist
- Unmet Supportive Care Needs Of Breast Cancer Survivors A Systematic Scoping Review
Gruppe 5: Identificering og opfølgning af sekundære sygdomme
- Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis
- Risk Of Second Primary Cancer Among Women In The Kaiser Permanente Breast Cancer Survivors Cohort
- Risk Of Second Primary Cancer Among Breast Cancer Patients A Systematic Review And Meta Analysis
- Risk Of Second Non Breast Cancer Among Patients Treated With And Without Postoperative Radiotherapy For Primary Breast Cancer
- Management Of Cancer Treatment Induced Bone Loss (CTIBL) In Patients With Breast Cancer Or Prostate Cancer
- A Review Of Research On The Intersection Between Breast Cancer And Cardiovascular Research In The Women’s Health Initiative (WHI)
- Once-Yearly Zoledronic Acid for treatment of postmenopausal osteoporosis
- Practical Guidance for the management of aromatase inhibitor-associated bone loss
- Influence of the anti-oestrogens tamoxifen and letrozole on thyroid function in women with early and advanced breast cancer: a systematic review
- aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal woman with early breast cancer
- The Effect of 6 Versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial
- Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism— A systematic review
Gruppe 6: Identificering og opfølgning af gener efter endokrin behandling
- Advances in the Management of Menopausal Symptoms, Fertility Preservation, and Bone Health for Women With Breast Cancer on Endocrine Therapy
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
- Effects Of Endocrine Therapy On Cognitive Function: A Comprehensive Review
- Efficacy of Cognitive Behavioral Therapy and Physical Exercise in Alleviating Treatment-Induced Menopausal Symptoms in Patients With Breast Cancer: Results of a Randomized, Controlled, Multicenter Trial
- Long Term Adjuvant Endocrine Therapy And Risk Of Cardiovascular Disease Systematic Review
- Norge Rehabilitering Rapport
- Osteoporotic Fractures After Adjuvant Endocrine Therapy A Meta Analysis
- Senfølge Abstracts
- Sexual Dysfunction A Crossectional Study ACTA
- Toxicity Of Adjuvant Endocrine Therapy In Postmenopausal Breast Cancer Patients A Systematic Review And Meta Analysis
Gruppe 7: Identificering og opfølgning af gener efter kemoterapi
- Prevention and Management of Chemotherapy-Induced Polyneuropathy
- Early breast cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up (Det er det kun follow-up-afsnit, du bedes kigge på)
- Long-Term Fatigue and Cognitive Disorders in Breast Cancer Survivors
- Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
- Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review
- Lessons Learned and Practice Pearls: Optimal Integration of Electronic Patient-Reported Outcomes in the Medical Oncology Clinic
Gruppe 8: Opfølgningskadence/Compliance/sårbare grupper
- Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation
- A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors
- Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark
- Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review
Yderligere litteratur
- Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial
- A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy
- Social inequality in cancer survivorship: Educational differences in health-related quality of life among 27,857 cancer survivors in Denmark
- Follow-up after treatment for breast cancer: One strategy fits all? An investigation of patient preferences using a discrete choice experiment
- Patients’ preferences for post-treatment breast cancer follow-up in primary care vs. secondary care: a qualitative study
- Patients’ Views of Follow-Up Care After Treatment for Breast Cancer: A Comparison of 2 Approaches
- Engagement in an Interactive App for Symptom Self-Management during Treatment in Patients With Breast or Prostate Cancer: Mixed Methods Study
- Patientpræferencerlitteratur Oversigt
- Follow-up Reality for Breast Cancer Patients – Standardised Survey of Patients and Physicians and Analysis of Treatment Data
- Intensive follow-up for women with breast cancer: review of clinical, economic and patient’s preference domains through evidence to decision framework
Fik du ikke givet feedback på DBCG Seminaret 2023?
Du kan nå det endnu👇
Har du spørgsmål? Skriv til os på cha@bpno.dk.
